2015, Volume 9, Issue 4
Stały URI dla tej kolekcji
Przeglądaj
Przeglądanie 2015, Volume 9, Issue 4 według Autor "Daniluk, Jadwiga"
Wyniki na stronie
Opcje wyszukiwania
-
RekordHealth behaviours of patients with cirrhosis(Państwowa Szkoła Wyższa im. Papieża Jana Pawła II w Białej Podlaskiej, 2016-02-03) Baczewska, Bożena ; Kropornicka, Beata ; Seweryn, Joanna ; Krzyżanowska, Ewa ; Nowicka, Elżbieta ; Daniluk, JadwigaThe aim of the study was to investigate and compare the health behaviours of patients with cirrhosis. The study was conducted from February to June 2012. Before starting the study, the consent was received by the Bioethics Committee at the Medical University of Lublin. The group of 92 patients with cirrhosis was examined, in Świętokrzyskie, Lubelskie and Mazowieckie voivodeships. The main criteria of selection were: known cirrhosis during the hospital treatment and acceptance for participation in the study. The Health Behaviour Inventory (IZZ) by Juczyński was extracted in the study. It contains 24 statements that describe the various types of health-related behaviours and are divided into 4 categories describing health behaviours. For the purposes of the evaluation such behaviours as: proper eating habits, proactive behaviours, health practices and positive mental attitude have been defined. The study group was characterized by average health behaviors, the results were within the 5 and 6 Sten. Studies have shown a higher intensity of health behaviors in the category of a positive mental attitude and proactive behaviour, while less intensity was visible in the category of proper eating habits and health practices. It has been shown that there are statistically significant differences between health behaviour, gender and age of the respondents. Women had significantly higher intensity of correct eating habits and proactive behaviours. Respondents aged 51 years old or older had the best health behaviours in all the categories of health behaviours. The study showed no statistically significant differences between health behaviour and the time of diagnosis, place of residence and education of the respondents.
-
RekordQuality of life of patients with type 2 diabetes in relation to method of treatment(Państwowa Szkoła Wyższa im. Papieża Jana Pawła II w Białej Podlaskiej, 2016-02) Dudzińska, Marta ; Tarach, Jerzy S. ; Zwolak, Agnieszka ; Malicka, Agnieszka ; Kowalczyk, Mariusz ; Daniluk, JadwigaInappropriate glycaemic control in type 2 diabetes leads to long-term complication and affects length of life. Intensification of treatment, involving insulin therapy is often delayed because of fear of negative influence on quality of life (QoL). Aims: evaluation of differences on QoL with type 2 diabetes patients in relation to method of current antidiabetic treatment, especially patients who are on the threshold of insulin therapy introduction. Methods: study involved 274 patients (mean 62.2years, 55.8%F) who were divided into 3 groups: patients treated with oral anti-diabetic agents (OAD group, n=111), patients, for whom insulin was introduced (Intensification group, n=68) and patients treated with insulin (Insulin group, n=95). QoL was measured with questionnaires: EQ-5D, DQL-BCI and DSC-R. Results: There were no statistically significant differences in EQ-5D indices among studied patients (OAD group-0.82, Intensification group–0.78, Insulin group–0.75). EQ-VAS among patients switched to insulin therapy was lower than in OAD group (52.7 and 59.3, respectively, p=0.004). The differences in DQL-BCI scores among all groups of patients were statistically insignificant (scores: OAD group-56.7, Intensification group-54.8, Insulin group-51.7). DSC-R score in Intensification group was higher than among OAD group (30.9 and 25.3, respectively, p=0,08). Patients switched to insulin therapy manifested the highest level of hyperglycemia-related burden and the lowest treatment satisfaction. Conclusions: patients whose treatment was intensified reported their QoL as lower than the patients treated with OAD, however there was no significant difference found in respect of QoL between patients from the latter group and patients already treated with insulin.